Advertisement

© 2010

Drug Management of Prostate Cancer

  • William D. Figg
  • Cindy H. Chau
  • Eric J. Small

Benefits

  • Provides a comprehensive guide to the spectrum of emerging pharmacologic agents

  • Covers both standard of care and investigational therapeutics

  • Written by recognized international authorities in the field

  • Well suited for clinicians actively involved in the medical management of patients with prostate cancer

Book

Table of contents

  1. Front Matter
    Pages i-xvii
  2. Hormone Therapy

    1. Front Matter
      Pages 25-25
    2. Martin E. Gleave, Michael E. Cox, Yuzhuo Wang
      Pages 1-24
  3. Hormone Therapy

    1. Front Matter
      Pages 25-25
    2. Douglas K. Price, Ann W. Hsing
      Pages 53-59
    3. Edward P. Gelmann
      Pages 61-70
    4. Howard C. Shen, Mary-Ellen Taplin, Steven P. Balk
      Pages 71-81
    5. Nima Sharifi
      Pages 101-107
    6. Francine Zanchetta Coelho Marques, Juergen K. V. Reichardt
      Pages 109-121
  4. Chemotherapy

    1. Front Matter
      Pages 123-123
    2. Patricia Halterman, Nicholas J. Vogelzang, Alireza Farabishahadel, Oscar B. Goodman Jr.
      Pages 125-131
    3. Courtney K. Phillips, Daniel P. Petrylak
      Pages 133-146
    4. Ashley Brick, Junyang Niu, Jiaoti Huang, William K. Oh
      Pages 153-161
    5. Tristan M. Sissung, William D. Figg
      Pages 163-177
    6. Antonio Tito Fojo, David E. Adelberg
      Pages 179-194

About this book

Introduction

This book is a comprehensive, concise summary of the pharmacological treatments of prostate cancer. It is an authoritative and up-to-date reference on therapeutic options involving both standard of care and investigational agents. The chapters describe state of the art information on Hormone Therapy, Chemotherapy, Angiogenesis, Therapy for Bone Metastases, Immunotherapy, Prevention, and Drug Development. Drug Management of Prostate Cancer is an excellent resource for medical oncologists, trainees, researchers, and members of the pharmaceutical industry

Keywords

Angiogenesis Bone Metastases Cancer Chemotherapy Drogen Drug Development Hormone Therapy Immunotherapy Management Medical Pharmacology Prevention Prostate pathophysiology physiology

Editors and affiliations

  • William D. Figg
    • 1
  • Cindy H. Chau
    • 2
  • Eric J. Small
    • 3
  1. 1.Medical Oncology BranchNIH National Cancer InstituteBethesdaUSA
  2. 2.Medical Oncology BranchNIH National Cancer InstituteBethesdaUSA
  3. 3.School of Medicine, Dept. UrologyUniversity of California, San FranciscoSan FranciscoUSA

Bibliographic information

  • Book Title Drug Management of Prostate Cancer
  • Editors William D. Figg
    Cindy H. Chau
    Eric J. Small
  • DOI https://doi.org/10.1007/978-1-60327-829-4
  • Copyright Information Springer Science+Business Media, LLC 2010
  • Publisher Name Springer, New York, NY
  • eBook Packages Medicine Medicine (R0)
  • Hardcover ISBN 978-1-60327-831-7
  • Softcover ISBN 978-1-4614-0184-1
  • eBook ISBN 978-1-60327-829-4
  • Edition Number 1
  • Number of Pages XVIII, 430
  • Number of Illustrations 12 b/w illustrations, 22 illustrations in colour
  • Topics Oncology
    Urology
    Internal Medicine
  • Buy this book on publisher's site
Industry Sectors
Biotechnology
Health & Hospitals
Oncology & Hematology
Pharma

Reviews

From the reviews:

“For medical oncologists, trainees, researchers, and those in the pharmaceutical industry, Figg … offer a comprehensive and concise summary of the pharmacological treatments for prostate cancer, both current standard and investigative options. The 36 chapters … focus on a multidisciplinary care approach and cover hormone therapy, chemotherapy, angiogenesis, therapy for bones metastases, immunotherapy, chemoprevention, and drug development. Cell biology and molecular targets are also discussed.” (SciTech Book News, December, 2010)

“The 36 chapters in this book … read as independent discussions of many of the most recent discoveries in the area of drug management of prostate cancer. … suitable for medical students, physicians in training, physicians (especially medical oncologists), scientists, translational researchers, and members of the pharmaceutical industry. … An important aspect of this book is that the data represents updated, state-of-the-art information, making it valuable for daily reference. … an excellent resource for readers interested in the management of advanced prostate cancer … .” (Jianqing Lin, Doody’s Review Service, December, 2010)

“This treatise is an exhaustive description of the application of drug management of prostate cancer involving both standard care and investigational agents. … this book will give the reader a detailed insight about the current knowledge from clinical trials into the drug treatment of prostate tumours. The urologists, medical oncologist and others involved in the treatment of the prostate cancer will find in this work a complete review of where we are now.” (M. Horňák, Neoplasma, March, 2011)

“This textbook by W.D. Figg and co-authors … makes an exhaustive overview of present and future medical therapies of prostate cancer. … This book provides the reader with comprehensive information about pharmacological treatments of prostate cancer. All chapters are concise and most of them are well-illustrated. We recommend this textbook to urologists, oncologists who are involved in prostate cancer management, and to all physicians and students who want to update their knowledge in prostate cancer management.” (European Urology Today, April/May, 2011)